Interactions_NNS among_IN Strategies_NP Associated_NP with_IN Bacterial_NP Infection_NP :_: Pathogenicity_NP ,_, Epidemicity_NP ,_, and_CC Antibiotic_JJ Resistance_NN Infections_NNS have_VBP been_VBN the_DT major_JJ cause_NN of_IN disease_NN throughout_IN the_DT history_NN of_IN human_JJ populations_NNS ._SENT With_IN the_DT introduction_NN of_IN antibiotics_NNS ,_, it_PP was_VBD thought_VBN that_IN this_DT problem_NN should_MD disappear_VB ._SENT However_RB ,_, bacteria_NNS have_VBP been_VBN able_JJ to_TO evolve_VB to_TO become_VB antibiotic_JJ resistant_NN ._SENT Nowadays_RB ,_, a_DT proficient_JJ pathogen_NN must_MD be_VB virulent_JJ ,_, epidemic_JJ ,_, and_CC resistant_JJ to_TO antibiotics_NNS ._SENT Analysis_NN of_IN the_DT interplay_NN among_IN these_DT features_NNS of_IN bacterial_JJ populations_NNS is_VBZ needed_VBN to_TO predict_VB the_DT future_NN of_IN infectious_JJ diseases_NNS ._SENT In_IN this_DT regard_NN ,_, we_PP have_VBP reviewed_VBN the_DT genetic_JJ linkage_NN of_IN antibiotic_JJ resistance_NN and_CC bacterial_JJ virulence_NN in_IN the_DT same_JJ genetic_JJ determinants_NNS as_RB well_RB as_IN the_DT cross_NN talk_NN between_IN antibiotic_JJ resistance_NN and_CC virulence_NN regulatory_JJ circuits_NNS with_IN the_DT aim_NN of_IN understanding_VBG the_DT effect_NN of_IN acquisition_NN of_IN resistance_NN on_IN bacterial_JJ virulence_NN ._SENT We_PP also_RB discuss_VB the_DT possibility_NN that_IN antibiotic_JJ resistance_NN and_CC bacterial_JJ virulence_NN might_MD prevail_VB as_IN linked_VBN phenotypes_NNS in_IN the_DT future_NN ._SENT The_DT novel_NN situation_NN brought_VBD about_RB by_IN the_DT worldwide_JJ use_NN of_IN antibiotics_NNS is_VBZ undoubtedly_RB changing_VBG bacterial_JJ populations_NNS ._SENT These_DT changes_NNS might_MD alter_VB the_DT properties_NNS of_IN not_RB only_RB bacterial_JJ pathogens_NNS ,_, but_CC also_RB the_DT normal_JJ host_NN microbiota_NN ._SENT The_DT evolutionary_JJ consequences_NNS of_IN the_DT release_NN of_IN antibiotics_NNS into_IN the_DT environment_NN are_VBP largely_RB unknown_JJ ,_, but_CC most_RBS probably_RB restoration_NN of_IN the_DT microbiota_NN from_IN the_DT preantibiotic_JJ era_NN is_VBZ beyond_IN our_PP$ current_JJ abilities_NNS ._SENT The_DT mechanisms_NNS involved_VBN in_IN the_DT virulence_NN (_( defined_VBN as_IN the_DT relative_JJ capacity_NN of_IN a_DT microbe_NN to_TO cause_VB damage_NN in_IN a_DT host_NN [_SYM ,_, ]_SYM )_) of_IN pathogenic_JJ bacteria_NNS as_RB well_RB as_IN those_DT determining_VBG antibiotic_JJ resistance_NN are_VBP important_JJ and_CC widely_RB studied_VBN topics_NNS in_IN clinical_JJ microbiology_NN ._SENT However_RB ,_, they_PP have_VBP rarely_RB been_VBN analyzed_VBN and_CC integrated_VBN as_IN we_PP intend_VBP to_TO do_VB in_IN the_DT present_JJ review_NN ._SENT In_IN terms_NNS of_IN evolution_NN and_CC ecology_NN ,_, antibiotic_JJ resistance_NN and_CC virulence_NN determinants_NNS share_VBP some_DT basic_JJ characteristics_NNS ._SENT Since_IN these_DT determinants_NNS have_VBP been_VBN acquired_VBN by_IN horizontal_JJ gene_NN transfer_NN from_IN other_JJ organisms_NNS ,_, many_JJ are_VBP examples_NNS of_IN what_WP has_VBZ been_VBN termed_VBN "_'' evolution_NN in_IN quantum_NN leaps_NNS "_'' ._SENT Also_RB ,_, most_JJS determinants_NNS serve_VBP to_TO escape_VB the_DT action_NN of_IN antibacterial_NN defense_NN systems_NNS that_WDT have_VBP developed_VBN either_RB by_IN natural_JJ (_( host_VB anti-infectious_JJ mechanisms_NNS )_) or_CC cultural_JJ (_( antibiotics_NNS )_) evolution_NN to_TO prevent_VB infections_NNS ._SENT Both_CC the_DT natural_JJ anti-infective_JJ defenses_NNS and_CC antibiotic_JJ treatments_NNS lead_VBP to_TO stringent_JJ conditions_NNS for_IN bacterial_JJ growth_NN ._SENT In_IN biology_NN ,_, any_DT limiting_VBG condition_NN for_IN the_DT majority_NN is_VBZ a_DT golden_JJ opportunity_NN for_IN the_DT minority_NN ._SENT Those_DT bacteria_NNS that_WDT are_VBP capable_JJ of_IN surviving_VBG and_CC multiplying_VBG under_IN these_DT conditions_NNS will_MD gain_VB access_NN to_TO organic_JJ spaces_NNS in_IN which_WDT competition_NN with_IN other_JJ microorganisms_NNS is_VBZ avoided_VBN (_( exclusive_JJ environments_NNS )_) ._SENT We_PP might_MD then_RB assume_VB that_IN both_DT virulence_NN and_CC antibiotic_JJ resistance_NN are_VBP formally_RB similar_JJ adaptive_JJ mechanisms_NNS selected_VBN to_TO survive_VB under_IN stress_NN conditions_NNS (_( either_CC host_NN invasion_NN or_CC antibiotic_JJ treatment_NN )_) ._SENT From_IN an_DT ecological_JJ point_NN of_IN view_NN ,_, both_CC infective_JJ conditions_NNS and_CC antibiotic_JJ treatments_NNS are_VBP evolutionary_JJ bottlenecks_NNS that_WDT tend_VBP to_TO reduce_VB microbial_JJ biodiversity_NN ,_, so_RB that_IN only_RB a_DT very_RB specific_JJ subset_NN of_IN bacteria_NNS are_VBP capable_JJ of_IN colonizing_VBG the_DT host_NN under_IN those_DT conditions_NNS ._SENT There_EX are_VBP several_JJ bacterial_JJ species_NNS that_WDT are_VBP able_JJ to_TO grow_VB at_IN 37C_JJ and_CC are_VBP tolerant_JJ to_TO the_DT oxygen_NN tension_NN present_JJ in_IN different_JJ parts_NNS of_IN the_DT human_JJ body_NN ._SENT The_DT fact_NN that_IN environmental_JJ microorganisms_NNS that_WDT are_VBP unable_JJ to_TO produce_VB disease_NN in_IN the_DT healthy_JJ host_NN frequently_RB infect_JJ immunocompromised_JJ patients_NNS indicates_VBZ that_IN many_JJ organisms_NNS are_VBP ecologically_RB compatible_JJ with_IN the_DT physicochemical_JJ conditions_NNS within_IN the_DT human_JJ body_NN ._SENT The_DT human_JJ body_NN and_CC its_PP$ physicochemical_JJ conditions_NNS are_VBP then_RB an_DT ecological_JJ space_NN that_WDT can_MD be_VB colonized_VBN by_IN several_JJ microorganisms_NNS ,_, frequently_RB with_IN an_DT environmental_JJ origin_NN ._SENT In_IN the_DT normal_JJ host_NN ,_, this_DT potential_NN for_IN colonization_NN is_VBZ limited_VBN by_IN the_DT immune_JJ system_NN ,_, which_WDT actively_RB impedes_VBZ colonization_NN of_IN the_DT human_JJ body_NN by_IN opportunistic_JJ pathogens_NNS ._SENT In_IN the_DT immunodepressed_JJ host_NN ,_, only_RB antibiotic_JJ treatment_NN maintains_VBZ a_DT small_JJ colonizable_JJ space_NN in_IN the_DT human_JJ body_NN (_( see_VB below_IN )_) ._SENT We_PP want_VBP then_RB to_TO go_VB one_CD step_NN beyond_IN ._SENT Is_VBZ there_RB any_DT evolutionary_JJ relationship_NN between_IN resistance_NN and_CC virulence_NN ?_SENT If_IN modern_JJ medicine_NN has_VBZ limited_VBN the_DT spread_NN and_CC maybe_RB the_DT evolution_NN of_IN bacterial_JJ pathogens_NNS ,_, this_DT has_VBZ been_VBN done_VBN at_IN the_DT expense_NN of_IN increasing_VBG antibiotic_JJ resistance_NN ._SENT Apparently_RB ,_, a_DT decrease_NN in_IN the_DT size_NN of_IN pathogenic_JJ populations_NNS and_CC an_DT increase_NN in_IN the_DT number_NN of_IN antibiotic-resistant_JJ microorganisms_NNS have_VBP characterized_VBN the_DT evolution_NN of_IN infectious_JJ diseases_NNS ._SENT In_IN pure_JJ theory_NN ,_, when_WRB the_DT number_NN of_IN pathogens_NNS decrease_VBP to_TO a_DT critical_JJ value_NN ,_, antibiotics_NNS should_MD be_VB less_RBR required_VBN ,_, and_CC restoration_NN of_IN antibiotic_JJ susceptibility_NN could_MD be_VB expected_VBN to_TO occur_VB ._SENT We_PP know_VBP ,_, however_RB ,_, that_IN this_DT is_VBZ not_RB true_JJ ._SENT The_DT widespread_JJ dissemination_NN of_IN antibiotic_JJ resistance_NN among_IN bacterial_JJ populations_NNS has_VBZ maintained_VBN or_CC even_RB increased_VBD the_DT number_NN of_IN harmful_JJ bacteria_NNS involved_VBN in_IN infections_NNS ._SENT In_IN fact_NN ,_, and_CC in_IN spite_NN of_IN previous_JJ claims_NNS ,_, infectious_JJ diseases_NNS are_VBP among_IN the_DT most_RBS prominent_JJ health_NN problem_NN nowadays_RB ,_, in_IN part_NN as_IN the_DT consequence_NN of_IN the_DT increasing_VBG number_NN of_IN antibiotic_JJ resistance_NN phenotypes_NNS ,_, which_WDT make_VBP bacterial_JJ infections_NNS untreatable_JJ by_IN current_JJ therapeutic_JJ protocols_NNS ._SENT If_IN new_JJ antibiotics_NNS and_CC protocols_NNS are_VBP required_VBN for_IN fighting_VBG infectious_JJ diseases_NNS ,_, we_PP must_MD first_RB understand_VB the_DT relationship_NN between_IN virulence_NN ,_, transmissibility_NN ,_, and_CC antibiotic_JJ resistance_NN ._SENT Thus_RB ,_, two_CD essential_JJ topics_NNS are_VBP first_RB reviewed_VBN in_IN this_DT work_NN :_: the_DT effect_NN of_IN acquisition_NN of_IN antibiotic_JJ resistance_NN (_( and_CC antibiotic_JJ treatment_NN )_) on_IN bacterial_JJ virulence_NN ,_, and_CC analysis_NN of_IN whether_IN pathogenicity_NN and_CC antibiotic_JJ resistance_NN might_MD prevail_VB as_IN linked_VBN phenotypes_NNS in_IN the_DT world_NN of_IN the_DT future_NN ,_, if_IN pathogens_NNS become_VBP antibiotic_JJ resistant_NN as_IN a_DT consequence_NN of_IN intense_JJ antibiotic_JJ selective_JJ pressure_NN ._SENT FIG._NN 1_CD ._SENT |_SYM Infection_NN and_CC antibiotic_JJ treatment_NN are_VBP both_CC stringent_JJ growing_VBG conditions_NNS ._SENT Infection_NN and_CC antibiotic_JJ treatment_NN are_VBP both_CC stringent_JJ growing_VBG conditions_NNS ._SENT Several_JJ bacteria_NNS are_VBP able_JJ to_TO grow_VB at_IN the_DT temperature_NN and_CC oxygen_NN tension_NN of_IN and_CC using_VBG the_DT nutrients_NNS present_JJ in_IN the_DT human_JJ body_NN ._SENT However_RB ,_, only_RB some_DT are_VBP able_JJ to_TO produce_VB infection_NN ;_: this_DT is_VBZ shownin_NN panel_NN A._NP Several_JJ bacterial_JJ species_NNS (_( ovals_NNS are_VBP pathogens_NNS ,_, circles_NNS are_VBP environmental_JJ ones_NNS )_) coexist_VBP outside_IN the_DT host_NN ._SENT Some_DT species_NNS are_VBP able_JJ to_TO displace_VB the_DT commensal_JJ flora_NN ,_, traverse_RB through_IN different_JJ epithelia_NNS ,_, resist_VB the_DT action_NN of_IN macrophages_NNS ,_, antibodies_NNS ,_, defensins_NNS (_( with_IN squares_NNS )_) ,_, and_CC all_PDT the_DT anti-infectious_JJ mechanisms_NNS of_IN the_DT human_JJ body_NN ,_, to_TO finally_RB reach_VB the_DT target_NN cells_NNS where_WRB the_DT disease_NN is_VBZ produced_VBN ._SENT At_IN any_DT of_IN these_DT sequential_JJ bottlenecks_NNS ,_, only_RB some_DT bacteria_NNS are_VBP selected_VBN ,_, and_CC their_PP$ population_NN is_VBZ further_RBR amplified_VBN ,_, so_RB that_IN ,_, from_IN the_DT high_JJ variability_NN of_IN bacteria_NNS that_WDT could_MD potentially_RB produce_VB the_DT disease_NN ,_, only_RB some_DT are_VBP really_RB pathogenic_JJ ._SENT In_IN panel_NN B_NP ,_, the_DT same_JJ situation_NN is_VBZ analyzed_VBN but_CC under_IN antibiotic_JJ treatment_NN (_( spheres_NNS )_) ._SENT In_IN this_DT case_NN ,_, only_RB a_DT small_JJ proportion_NN of_IN the_DT cells_NNS belonging_VBG to_TO the_DT infectious_JJ species_NNS (_( the_DT antibiotic-resistant_JJ ones_NNS ;_: blue_JJ ovals_NNS with_IN a_DT red_JJ line_NN )_) are_VBP able_JJ to_TO produce_VB infection_NN ,_, so_RB that_IN the_DT antibiotic-treated_JJ host_NN is_VBZ a_DT more_RBR stringent_JJ ecosystem_NN for_IN the_DT growth_NN of_IN bacteria_NNS ._SENT However_RB ,_, in_IN the_DT case_NN of_IN a_DT debilitated_VBN person_NN (_( panel_NN C_NP )_) ,_, the_DT situation_NN is_VBZ somewhat_RB different_JJ ._SENT In_IN these_DT patients_NNS ,_, the_DT indigenous_JJ microflora_NN might_MD be_VB removed_VBN because_IN of_IN antibiotic_JJ use_NN ,_, the_DT epithelial_JJ integrity_NN may_MD be_VB impaired_JJ (_( intubated_VBN patients_NNS )_) ,_, the_DT immune_JJ system_NN can_MD be_VB abolished_VBN (_( immunocompromised_JJ patients_NNS )_) ,_, and_CC even_RB the_DT target_NN cells_NNS can_MD change_VB ._SENT Under_IN these_DT circumstances_NNS ,_, some_DT environmental_JJ species_NN can_MD produce_VB infection_NN (_( opportunistic_JJ pathogens_NNS )_) ,_, because_IN growth_NN conditions_NNS are_VBP less_RBR stringent_JJ ._SENT However_RB ,_, at_IN least_JJS in_IN the_DT developed_VBN world_NN ,_, those_DT patients_NNS are_VBP usually_RB under_IN heavy_JJ antibiotic_JJ treatment_NN ,_, frequently_RB with_IN a_DT combination_NN of_IN antibiotics_NNS (_( golden_JJ and_CC blue_JJ spheres_NNS )_) ,_, so_RB that_IN only_RB those_DT species_NN with_IN an_DT intrinsically_RB antibiotic-resistant_JJ phenotype_NN can_MD produce_VB the_DT infection_NN ._SENT Under_IN these_DT circumstances_NNS ,_, the_DT main_JJ selective_JJ force_NN is_VBZ antibiotics_NNS ,_, so_RB that_DT antibiotic_JJ treatment_NN becomes_VBZ a_DT risk_NN factor_NN for_IN some_DT pathogens_NNS ._SENT Virulent_JJ bacteria_NNS have_VBP acquired_VBN their_PP$ phenotype_NN through_IN a_DT long_JJ evolutionary_JJ course_NN in_IN close_JJ contact_NN with_IN their_PP$ natural_JJ hosts_NNS ._SENT Most_JJS virulence_NN determinants_NNS are_VBP either_RB located_VBN in_IN chromosomal_JJ gene_NN clusters_NNS (_( pathogenicity_NN islands_NNS )_) or_CC harbored_VBN in_IN genetic_JJ accessory_JJ elements_NNS such_JJ as_IN plasmids_NNS and_CC phages_NNS ._SENT This_DT suggests_VBZ that_DT evolution_NN from_IN an_DT avirulent_JJ way_NN of_IN life_NN to_TO pathogenicity_NN frequently_RB implies_VBZ the_DT acquisition_NN of_IN foreign_JJ pieces_NNS of_IN DNA_NP ._SENT Nevertheless_RB ,_, for_IN the_DT organism_NN to_TO be_VB a_DT real_JJ pathogen_NN ,_, these_DT pathogenicity_NN factors_NNS should_MD be_VB inserted_VBN in_IN an_DT organism_NN ecologically_RB compatible_JJ with_IN the_DT potential_JJ host_NN ._SENT Moreover_RB ,_, in_IN some_DT cases_NNS it_PP is_VBZ not_RB an_DT acquisition_NN but_CC a_DT deletion_NN (_( virulence-associated_JJ "_`` black_JJ holes_NNS "_'' )_) which_WDT is_VBZ needed_VBN to_TO become_VB a_DT pathogen_NN ._SENT Indeed_RB ,_, any_DT change_NN in_IN lifestyle_NN has_VBZ a_DT biological_JJ cost_NN ,_, as_IN functions_NNS needed_VBN in_IN one_CD habitat_NN may_MD cause_VB a_DT burden_NN in_IN another_DT habitat_NN and_CC could_MD therefore_RB be_VB counterselected_VBN ._SENT Acquisition_NN of_IN a_DT virulence_NN phenotype_NN might_MD then_RB require_VB the_DT acquisition_NN of_IN some_DT different_JJ pathogenicity_NN islands_NNS and_CC the_DT loss_NN of_IN some_DT chromosomal_JJ DNA_NN regions_NNS ._SENT Therefore_RB ,_, the_DT construction_NN of_IN a_DT pathogen_NN by_IN the_DT acquisition_NN of_IN specific_JJ pathogenic_JJ elements_NNS in_IN ecologically_RB compatible_JJ host-adapted_JJ bacterial_JJ genomes_NNS has_VBZ probably_RB occurred_VBN over_IN a_DT long_JJ evolutionary_JJ time_NN ._SENT In_IN this_DT regard_NN ,_, the_DT record_NN of_IN infectious_JJ diseases_NNS (_( mainly_RB epidemic_JJ ones_NNS )_) in_IN human_JJ history_NN and_CC bioarchaeological_JJ analysis_NN of_IN the_DT paleontological_JJ record_NN indicate_VBP that_IN we_PP have_VBP been_VBN in_IN contact_NN with_IN pathogens_NNS similar_JJ to_TO those_DT currently_RB producing_VBG infections_NNS for_IN a_DT long_JJ time_NN ._SENT In_IN this_DT way_NN ,_, it_PP has_VBZ been_VBN demonstrated_VBN that_IN infectious_JJ diseases_NNS such_JJ as_IN syphilis_NN ,_, tuberculosis_NN ,_, and_CC other_JJ infections_NNS due_JJ to_TO bacteria_NNS ,_, viruses_NNS ,_, and_CC parasites_NNS were_VBD common_JJ in_IN prehistoric_JJ men_NNS ,_, particularly_RB in_IN the_DT Neolithic_JJ age_NN ,_, when_WRB agriculture_NN and_CC farming_NN ensured_VBD close_JJ contact_NN between_IN humans_NNS and_CC between_IN humans_NNS and_CC animals_NNS ._SENT In_IN some_DT cases_NNS ,_, however_RB ,_, such_JJ evolution_NN has_VBZ occurred_VBN in_IN historical_JJ times_NNS ,_, as_IN the_DT evolution_NN from_IN Yersinia_NP pseudotuberculosis_NN to_TO Y._NP pestis_NN ,_, which_WDT was_VBD shortly_RB followed_VBN by_IN the_DT first_JJ pandemic_JJ plagues_NNS ._SENT Obviously_RB ,_, the_DT evolutionary_JJ outcome_NN of_IN pathogenic_JJ organisms_NNS tends_VBZ to_TO be_VB limited_VBN in_IN modern_JJ times_NNS by_IN the_DT anti-infectious_JJ repertoire_NN developed_VBN by_IN humans_NNS that_WDT includes_VBZ hygienic_JJ measures_NNS ,_, epidemiological_JJ controls_NNS ,_, vaccines_NNS ,_, and_CC ,_, significantly_RB ,_, antibiotics_NNS ._SENT Conversely_RB ,_, acquisition_NN and_CC further_JJR spread_NN of_IN antibiotic_JJ resistance_NN genes_NNS among_IN pathogenic_JJ bacteria_NNS is_VBZ a_DT phenomenon_NN that_WDT has_VBZ occurred_VBN just_RB in_IN the_DT last_JJ 50_CD years_NNS as_IN a_DT consequence_NN of_IN extensive_JJ antibiotic_JJ use_NN for_IN human_JJ therapy_NN and_CC animal_NN farming_NN ._SENT At_IN first_JJ glance_NN ,_, pathogenicity_NN and_CC resistance_NN should_MD be_VB unlinked_JJ phenomena_NNS ._SENT However_RB ,_, several_JJ examples_NNS indicate_VBP that_IN this_DT is_VBZ not_RB the_DT situation_NN for_IN several_JJ bacterial_JJ pathogens_NNS ._SENT Antibiotic_JJ resistance_NN and_CC virulence_NN genes_NNS can_MD be_VB linked_VBN (_( and_CC then_RB coselected_JJ )_) in_IN the_DT same_JJ replicon_NN ,_, or_CC eventually_RB a_DT single_JJ determinant_NN can_MD be_VB involved_VBN in_IN both_DT virulence_NN and_CC resistance_NN ._SENT Some_DT examples_NNS of_IN these_DT situations_NNS will_MD be_VB reviewed_VBN ._SENT In_IN this_DT section_NN ,_, we_PP analyze_VBP whether_IN a_DT mechanism_NN which_WDT has_VBZ been_VBN selected_VBN on_IN the_DT basis_NN of_IN a_DT bacterial_JJ virulence_NN phenotype_NN might_MD also_RB be_VB relevant_JJ for_IN antibiotic_JJ resistance_NN and_CC vice_JJ versa_RB ._SENT Let_VB us_PP first_RB examine_VBP the_DT effect_NN of_IN the_DT spatial_JJ localization_NN of_IN bacteria_NNS in_IN the_DT human_JJ body_NN ._SENT Several_JJ virulent_JJ bacteria_NNS base_VBP their_PP$ pathogenic_JJ characteristics_NNS in_IN an_DT intracellular_JJ way_NN of_IN life_NN during_IN infection_NN ._SENT Internalization_NN may_MD be_VB required_VBN for_IN the_DT induction_NN of_IN inflammatory_JJ cytokines_NNS and_CC produce_VB tissue_NN damage_NN through_IN the_DT induction_NN of_IN either_DT necrotic_JJ or_CC apoptotic_JJ responses_NNS ._SENT A_DT remarkable_JJ example_NN is_VBZ the_DT apoptosis_NN of_IN macrophages_NNS induced_VBN by_IN pathogens_NNS such_JJ as_IN Shigella_NP ,_, which_WDT both_CC avoid_VB the_DT antibacterial_NN effect_NN of_IN those_DT cells_NNS and_CC trigger_NN inflammation_NN ._SENT In_IN some_DT well-characterized_JJ examples_NNS ,_, bacteria_NNS are_VBP able_JJ to_TO travel_VB from_IN cell_NN to_TO cell_NN without_IN any_DT significant_JJ contact_NN with_IN the_DT extracellular_JJ milieu_NN ,_, thus_RB avoiding_VBG the_DT immune_JJ system_NN as_RB well_RB as_IN contact_NN with_IN antibiotics_NNS that_WDT do_VBP not_RB enter_VB mammalian_JJ cells_NNS ._SENT This_DT provides_VBZ the_DT first_JJ clue_NN as_IN to_TO how_WRB well-characterized_JJ virulence_NN phenotypes_NNS can_MD be_VB related_VBN to_TO antibiotic_JJ resistance_NN ._SENT Mammalian_JJ cells_NNS are_VBP poorly_RB permeable_JJ to_TO or_CC easily_RB exclude_VB several_JJ families_NNS of_IN antibiotics_NNS ._SENT Even_RB if_IN the_DT antibiotic_NN enters_VBZ the_DT mammalian_JJ cells_NNS ,_, intracellular_JJ growth_NN might_MD induce_VB a_DT transient_JJ antibiotic-resistant_JJ phenotype_NN ,_, a_DT situation_NN that_WDT has_VBZ been_VBN described_VBN for_IN Legionella_NP pneumophila_NP ._SENT The_DT location_NN within_IN the_DT host_NN may_MD alter_VB in_IN an_DT unspecific_JJ way_NN the_DT susceptibility_NN of_IN the_DT bacterial_JJ organism_NN to_TO antibiotics_NNS ._SENT Haemophilus_NP influenzae_NP grown_VBN in_IN animals_NNS undergoes_VBZ modifications_NNS in_IN penicillin-binding_NN proteins_NNS ,_, as_IN peptidoglycan_NN metabolism_NN is_VBZ directly_RB affected_VBN by_IN the_DT environment_NN ,_, and_CC Salmonella_NP peptidoglycan_NP is_VBZ dramatically_RB altered_VBN for_IN bacteria_NNS growing_VBG intracellularly_RB ._SENT Although_IN the_DT effect_NN of_IN these_DT changes_NNS on_IN antibiotic_JJ susceptibility_NN has_VBZ not_RB been_VBN analyzed_VBN extensively_RB ,_, it_PP is_VBZ possible_JJ that_IN those_DT metabolic_JJ changes_NNS may_MD alter_VB the_DT activity_NN of_IN antibiotics_NNS such_JJ as_IN beta-lactams_NNS against_IN bacteria_NNS growing_VBG during_IN infection_NN ._SENT It_PP is_VBZ then_RB possible_JJ that_IN intracellular_JJ localization_NN may_MD allow_VB bacteria_NNS to_TO maintain_VB a_DT phenotype_NN of_IN antibiotic_JJ resistance_NN ._SENT In_IN this_DT respect_NN ,_, treatment_NN with_IN some_DT antibiotics_NNS might_MD select_VB for_IN intracellular_JJ clones_NNS ._SENT This_DT could_MD be_VB the_DT case_NN for_IN species_NNS in_IN which_WDT some_DT clones_NNS are_VBP able_JJ to_TO invade_VB mammalian_JJ cells_NNS and_CC others_NNS are_VBP noninvasive_JJ ;_: one_CD such_JJ species_NNS is_VBZ Pseudomonas_NP aeruginosa_NP ._SENT On_IN the_DT contrary_NN ,_, some_DT antibiotics_NNS ,_, such_JJ as_IN macrolides_NNS and_CC fluoroquinolones_NNS ,_, are_VBP actively_RB accumulated_VBN by_IN human_JJ cells_NNS ._SENT In_IN this_DT case_NN ,_, intracellular_JJ bacterial_JJ localization_NN might_MD eventually_RB increase_VB the_DT antibiotic_JJ effect_NN against_IN bacterial_JJ pathogens_NNS ,_, leading_VBG to_TO better_JJR eradication_NN and_CC favoring_VBG the_DT less_RBR invasive_JJ strains_NNS ._SENT A_DT similar_JJ situation_NN of_IN phenotypic_JJ antibiotic_JJ resistance_NN can_MD be_VB observed_VBN for_IN bacteria_NNS growing_VBG in_IN biofilms_NNS ._SENT Bacterial_JJ biofilms_NNS are_VBP frequent_JJ in_IN persistent_JJ infections_NNS ,_, such_JJ as_IN those_DT associated_VBN with_IN cystic_JJ fibrosis_NN ,_, chronic_JJ bronchitis_NN ,_, osteomyelitis_NN ,_, and_CC foreign-body-associated_JJ infections_NNS ._SENT Bacteria_NNS growing_VBG in_IN biofilms_NNS are_VBP more_RBR resistant_JJ than_IN those_DT under_IN a_DT planktonic_JJ way_NN of_IN life_NN to_TO the_DT action_NN of_IN phagocytic_JJ cells_NNS '_POS antibacterial_NN activity_NN as_RB well_RB as_IN the_DT action_NN of_IN antibiotics_NNS ._SENT As_RB in_IN the_DT previous_JJ case_NN ,_, antibiotics_NNS might_MD select_VB biofilm-forming_JJ organisms_NNS ,_, thereby_RB increasing_VBG the_DT prevalence_NN of_IN chronic_JJ infections_NNS ._SENT Other_JJ mechanisms_NNS of_IN virulence_NN could_MD prevent_VB the_DT action_NN of_IN antibiotics_NNS against_IN bacteria_NNS ._SENT For_IN instance_NN ,_, toxins_NNS leading_VBG to_TO local_JJ necrosis_NN or_CC abscess_NN formation_NN certainly_RB will_MD decrease_VB the_DT local_JJ availability_NN of_IN antibiotics_NNS due_JJ to_TO reduction_NN in_IN antibiotic_JJ arrival_NN to_TO the_DT foci_NNS or_CC because_IN of_IN local_JJ inactivation_NN of_IN the_DT drugs_NNS by_IN altered_JJ pH_NN ,_, free_JJ proteins_NNS ,_, or_CC DNA_NP ._SENT In_IN these_DT cases_NNS ,_, the_DT mechanisms_NNS of_IN pathogenicity_NN may_MD finally_RB serve_VB as_IN mechanisms_NNS for_IN antibiotic_JJ resistance_NN ._SENT A_DT final_JJ example_NN of_IN a_DT virulence_NN mechanism_NN with_IN a_DT role_NN in_IN antibiotic_JJ resistance_NN is_VBZ presented_VBN by_IN Bordetella_NP pertussis_NN ,_, the_DT etiological_JJ agent_NN of_IN whooping_JJ cough_NN ._SENT The_DT cell_NN wall_NN of_IN the_DT virulent_JJ strains_NNS of_IN this_DT microorganism_NN is_VBZ infrequently_RB susceptible_JJ to_TO autolysis_NN triggered_VBD by_IN beta-lactam_NN antibiotics_NNS ;_: only_RB avirulent_JJ B._NP pertussis_NN strains_NNS are_VBP known_VBN to_TO be_VB lysed_VBN ._SENT It_PP was_VBD demonstrated_VBN that_IN this_DT phenotypic_JJ tolerance_NN and_CC the_DT antibiotic-induced_JJ autolytic_JJ activity_NN are_VBP controlled_VBN by_IN the_DT vir_NN locus_NN ,_, which_WDT determines_VBZ phase_NN transition_NN in_IN B._NP pertussis_NN ,_, a_DT key_JJ element_NN in_IN the_DT virulence_NN properties_NNS of_IN this_DT bacterial_JJ species_NN ._SENT In_IN previous_JJ examples_NNS ,_, we_PP have_VBP seen_VBN that_IN a_DT "_`` virulent_JJ way_NN of_IN life_NN "_`` can_MD contribute_VB to_TO an_DT antibiotic_JJ resistance_NN phenotype_NN ._SENT Could_MD antibiotic_JJ resistance_NN determinants_NNS also_RB contribute_VBP to_TO bacterial_JJ virulence_NN ?_SENT Some_DT examples_NNS suggest_VBP that_IN this_DT could_MD be_VB the_DT case_NN ._SENT Recently_RB ,_, one_CD area_NN of_IN intense_JJ study_NN of_IN antibiotic_JJ resistance_NN is_VBZ the_DT analysis_NN of_IN multidrug_NN resistance_NN (_( MDR_NP )_) efflux_NN pumps_NNS ._SENT These_DT determinants_NNS are_VBP able_JJ to_TO extrude_VB an_DT ample_JJ range_NN of_IN substances_NNS that_WDT include_VBP antibiotics_NNS ,_, solvents_NNS ,_, dyes_NNS ,_, and_CC quorum-sensing_VBG signals_NNS ._SENT Extrusion_NN by_IN the_DT same_JJ pump_NN of_IN compounds_NNS as_IN diverse_JJ as_IN erythromycin_NN ,_, quinolones_NNS ,_, beta-lactams_NNS ,_, and_CC ethidium_NN bromide_NN is_VBZ a_DT rule_NN more_RBR than_IN an_DT exception_NN ._SENT Might_MD these_DT MDR_NP determinants_NNS extrude_VBP compounds_NNS involved_VBN in_IN the_DT host_NN defense_NN be_VB contributing_VBG to_TO bacterial_JJ virulence_NN ?_SENT The_DT answer_NN is_VBZ yes_UH ._SENT For_IN instance_NN ,_, adaptation_NN to_TO growth_NN in_IN the_DT presence_NN of_IN bile_NN salts_NNS is_VBZ a_DT prerequisite_NN for_IN any_DT pathogen_NN to_TO colonize_VB the_DT intestinal_JJ tract_NN ._SENT It_PP has_VBZ been_VBN reported_VBN that_IN Escherichia_NP coli_NNS extrudes_VBZ bile_NN salts_NNS through_IN the_DT acrAB_NN system_NN ,_, which_WDT was_VBD first_RB characterized_VBN as_IN an_DT MDR_NP determinant_NN ;_: the_DT same_JJ occurs_VBZ in_IN Salmonella_NP enterica_NP serotype_NN Typhimurium_NN ._SENT In_IN fact_NN ,_, it_PP has_VBZ been_VBN suggested_VBN that_DT extrusion_NN of_IN bile_NN salts_NNS present_JJ in_IN the_DT intestinal_JJ ecosystem_NN to_TO which_WDT these_DT bacteria_NNS are_VBP adapted_VBN is_VBZ the_DT function_NN for_IN which_WDT those_DT MDR_NP determinants_NNS were_VBD selected_VBN ._SENT Analysis_NN of_IN S._NP enterica_NP serotype_NN Typhimurium_NN mutants_NNS with_IN high_JJ susceptibility_NN to_TO bile_NN salts_NNS has_VBZ demonstrated_VBN that_IN this_DT higher_JJR susceptibility_NN was_VBD a_DT consequence_NN of_IN inactivation_NN of_IN the_DT MDR_NP determinant_JJ acrB_NN ._SENT This_DT inactivation_NN leads_VBZ to_TO a_DT reduced_VBN ability_NN to_TO colonize_VB the_DT intestinal_JJ tract_NN in_IN a_DT murine_JJ infection_NN model_NN ,_, which_WDT indicates_VBZ that_IN acrAB_NN is_VBZ involved_VBN in_IN both_DT antibiotic_JJ resistance_NN and_CC virulence_NN ._SENT Some_DT MDR_NP systems_NNS ,_, such_JJ as_IN Mtr_NP from_IN Neisseria_NP gonorrhoeae_NNS and_CC SapA_NP from_IN S._NP enterica_NP serotype_NN Typhimurium_NN ,_, can_MD actively_RB extrude_VB both_DT defensins_NNS and_CC antibiotics_NNS ,_, thus_RB contributing_VBG to_TO reducing_VBG antibiotic_JJ susceptibility_NN as_IN well_RB as_RB to_TO increasing_VBG the_DT number_NN of_IN virulence_NN determinants_NNS of_IN the_DT organisms_NNS ._SENT In_IN fact_NN ,_, it_PP has_VBZ been_VBN described_VBN that_DT resistance_NN to_TO defensins_NNS is_VBZ required_VBN for_IN a_DT full_JJ virulence_NN phenotype_NN in_IN the_DT case_NN of_IN Salmonella_NP ._SENT The_DT mechanisms_NNS of_IN action_NN of_IN defensins_NNS resemble_VBP at_IN least_JJS in_IN part_NN that_IN of_IN peptidic_JJ antibiotics_NNS currently_RB used_VBN in_IN clinical_JJ practice_NN ._SENT Thus_RB ,_, it_PP is_VBZ conceivable_JJ that_IN they_PP might_MD share_VB the_DT same_JJ mechanisms_NNS for_IN resistance_NN ._SENT This_DT situation_NN has_VBZ been_VBN described_VBN for_IN polymixin_NP B._NP The_DT sensitivities_NNS to_TO polycationic_JJ peptides_NNS were_VBD compared_VBN between_IN two_CD groups_NNS of_IN Yersinia_NP enterocolitica_NP isolates_VBZ ,_, one_CD with_IN an_DT environmental_JJ origin_NN and_CC the_DT other_JJ from_IN infections_NNS ._SENT Data_NNS indicated_VBD that_IN pathogenic_JJ strains_NNS of_IN Y._NP enterocolitica_NP were_VBD resistant_JJ to_TO defensins_NNS and_CC also_RB to_TO polymixin_NP B_NP ,_, showing_VBG a_DT clear_JJ cross-linkage_NN between_IN antibiotic_JJ resistance_NN and_CC virulence_NN as_IN a_DT consequence_NN of_IN the_DT expression_NN of_IN a_DT resistance_NN determinant_NN ._SENT Not_RB only_RB MDR_NP pumps_NNS but_CC also_RB biocide_NN efflux_NN determinants_NNS may_MD play_VB a_DT role_NN in_IN bacterial_JJ virulence_NN ._SENT It_PP has_VBZ been_VBN reported_VBN that_IN the_DT QacA_NP pump_NN of_IN Staphylococcus_NP aureus_NN ,_, involved_VBN in_IN resistance_NN to_TO several_JJ organic_JJ cations_NNS (_( biocides_NNS included_VBD )_) ,_, has_VBZ a_DT role_NN in_IN resistance_NN to_TO thrombin-induced_JJ platelet_NN microbicidal_JJ protein_NN ._SENT Thus_RB ,_, the_DT presence_NN of_IN the_DT pump_NN contributes_VBZ to_TO the_DT survival_NN of_IN strains_NNS carrying_VBG this_DT determinant_NN at_IN sites_NNS of_IN endothelial_JJ damage_NN as_IN well_RB as_RB in_IN experimental_JJ endovascular_JJ infections_NNS ._SENT We_PP want_VBP to_TO stress_VB here_RB that_IN the_DT mechanisms_NNS of_IN extrusion_NN of_IN antibiotics_NNS are_VBP similar_JJ to_TO those_DT translocating_VBG some_DT proteins_NNS involved_VBN in_IN pathogenicity_NN ._SENT The_DT hemolysin_NN export_NN apparatus_NN in_IN Escherichia_NP coli_NNS comprises_VBZ the_DT outer_JJ membrane_NN channel_NN trimmer_JJR protein_NN TolC_NN that_WDT is_VBZ also_RB involved_VBN in_IN the_DT AcrA-B_NP multidrug_NN efflux_NN transport_NN complex_NN ._SENT The_DT periplasmic_JJ proteins_NNS of_IN both_DT systems_NNS ,_, AcrA_NP and_CC HlyD_NP ,_, have_VBP a_DT similar_JJ structure_NN and_CC are_VBP able_JJ to_TO interact_VB with_IN TolC_NP ._SENT In_IN all_DT previously_RB discussed_VBN examples_NNS ,_, a_DT mechanism_NN selected_VBN for_IN bacterial_JJ virulence_NN can_MD also_RB produce_VB an_DT antibiotic_JJ resistance_NN phenotype_NN ._SENT Selection_NN for_IN the_DT most_RBS virulent_JJ strains_NNS might_MD select_VB for_IN antibiotic_JJ resistance_NN ,_, and_CC conversely_RB ,_, selection_NN for_IN antibiotic_JJ resistance_NN might_MD select_VB the_DT most_RBS virulent_JJ microorganisms_NNS ._SENT However_RB ,_, the_DT opposite_JJ situation_NN can_MD also_RB be_VB found_VBN :_: antibiotic_JJ resistance_NN may_MD decrease_VB bacterial_JJ virulence_NN (_( see_VB below_IN )_) ._SENT For_IN instance_NN ,_, the_DT KatG_NP catalase-peroxidase_NN activity_NN is_VBZ important_JJ for_IN the_DT survival_NN of_IN Mycobacterium_NN tuberculosis_NN in_IN the_DT host_NN ._SENT Mutations_NNS that_WDT eliminate_VBP this_DT activity_NN prevent_VB the_DT activation_NN of_IN isoniazid_NN and_CC are_VBP the_DT major_JJ cause_NN of_IN resistance_NN to_TO this_DT drug_NN in_IN Mycobacterium_NP spp._NP ._SENT It_PP might_MD then_RB be_VB predicted_VBN that_IN isoniazid-resistant_JJ Mycobacterium_NN mutants_NNS might_MD be_VB less_RBR virulent_JJ than_IN wild-type_JJ isoniazid-susceptible_JJ strains_NNS ,_, at_IN least_JJS in_IN the_DT case_NN of_IN M._NP tuberculosis_NN and_CC Mycobacterium_NN bovis_NNS ._SENT However_RB ,_, when_WRB isoniazid-resistant_JJ isolates_NNS were_VBD analyzed_VBN ,_, such_JJ reduced_JJ virulence_NN was_VBD not_RB found_VBN ._SENT It_PP turned_VBD out_RP that_DT M._NP tuberculosis_NN pathogenic_JJ isolates_NNS accumulate_VBP compensatory_JJ mutations_NNS in_IN the_DT gene_NN encoding_VBG the_DT alkyl_NN peroxidase_NN AphC_NP ,_, which_WDT can_MD substitute_VB for_IN KatG_NP for_IN survival_NN inside_IN the_DT host_NN ._SENT It_PP is_VBZ largely_RB assumed_VBN that_DT acquisition_NN of_IN novel_JJ genetic_JJ determinants_NNS may_MD have_VB a_DT cost_NN for_IN the_DT bacterial_JJ host_NN ._SENT That_DT may_MD happen_VB because_IN of_IN partial_JJ incompatibility_NN of_IN previous_JJ and_CC acquired_JJ lifestyles_NNS ,_, or_CC because_IN of_IN the_DT extra_JJ energy_NN required_VBN to_TO maintain_VB the_DT genetic_JJ vectors_NNS carrying_VBG the_DT new_JJ genes_NNS ._SENT The_DT acquisition_NN of_IN plasmids_NNS or_CC antibiotic_JJ resistance-virulence_NN genes_NNS might_MD have_VB an_DT effect_NN on_IN bacterial_JJ fitness_NN ._SENT As_IN previously_RB stated_VBN ,_, pathogenicity_NN islands_NNS ,_, acquired_VBN through_IN horizontal_JJ transfer_NN of_IN large_JJ gene_NN arrangements_NNS ,_, have_VBP a_DT major_JJ role_NN in_IN bacterial_JJ virulence_NN ._SENT Also_RB ,_, large_JJ vir_NN plasmids_NNS are_VBP needed_VBN for_IN some_DT pathogens_NNS ,_, such_JJ as_IN Shigella_NP and_CC Yersinia_NP ,_, to_TO express_VB a_DT pathogenic_JJ phenotype_NN ._SENT We_PP might_MD speculate_VB that_DT acquisition_NN of_IN these_DT determinants_NNS implied_VBD a_DT cost_NN in_IN bacterial_JJ fitness_NN when_WRB they_PP were_VBD included_VBN in_IN the_DT genome_NN of_IN the_DT previously_RB nonvirulent_JJ bacteria_NNS ._SENT However_RB ,_, acquisition_NN of_IN resistance_NN genes_NNS by_IN pathogenic_JJ bacteria_NNS has_VBZ occurred_VBN over_IN the_DT last_JJ 50_CD years_NNS ,_, but_CC acquisition_NN and_CC further_JJR evolution_NN of_IN structures_NNS as_IN pathogenicity_NN islands_NNS occurred_VBD thousands_NNS of_IN years_NNS ago_RB ._SENT Thus_RB ,_, the_DT evolutionary_JJ time_NN needed_VBN to_TO acquire_VB and_CC optimize_VB compensatory_JJ mutations_NNS to_TO alleviate_VB the_DT effect_NN on_IN fitness_NN of_IN the_DT acquisition_NN of_IN pathogenicity_NN determinants_NNS has_VBZ been_VBN much_RB longer_JJR ._SENT Also_RB ,_, for_IN plasmids_NNS carrying_VBG vir_NN determinants_NNS ,_, the_DT costs_NNS of_IN the_DT acquisition_NN of_IN such_JJ determinants_NNS might_MD be_VB compensated_VBN for_IN by_IN mutations_NNS in_IN other_JJ loci_NNS ._SENT Of_IN note_NN ,_, it_PP has_VBZ been_VBN shown_VBN that_IN the_DT vir_NN plasmid_NN can_MD be_VB easily_RB lost_VBN in_IN vitro_NN in_IN Shigella_NP ._SENT However_RB ,_, growth_NN conditions_NNS in_IN vivo_RB should_MD preserve_VB the_DT plasmid_NN 's_POS presence_NN during_IN infection_NN ,_, otherwise_RB Shigella_NP would_MD not_RB be_VB virulent_JJ anymore_RB ._SENT Acquisition_NN of_IN vir_NN plasmids_NNS ensures_VBZ the_DT ability_NN to_TO colonize_VB a_DT different_JJ biological_JJ compartment_NN ,_, thus_RB evading_VBG competition_NN with_IN other_JJ bacterial_JJ species_NNS and_CC eventually_RB reducing_VBG the_DT potential_JJ fitness_NN cost_NN imposed_VBN by_IN the_DT new_JJ genetic_JJ element_NN ._SENT The_DT same_JJ has_VBZ probably_RB occurred_VBN for_IN enteroinvasive_JJ E._NP coli_NNS isolates_NNS ._SENT Recent_JJ work_NN suggests_VBZ that_IN the_DT invasive_JJ ability_NN of_IN those_DT isolates_NNS has_VBZ evolved_VBN in_IN different_JJ chromosomal_JJ backgrounds_NNS ,_, probably_RB through_IN the_DT spread_NN of_IN plasmid-borne_JJ invasion_NN genes_NNS ,_, and_CC the_DT maintenance_NN of_IN invasive_JJ phenotypes_NNS in_IN separate_JJ lineages_NNS suggests_VBZ that_IN this_DT ability_NN confers_VBZ a_DT selective_JJ advantage_NN to_TO invasive_JJ strains_NNS ._SENT Although_IN the_DT Ewald_NP hypothesis_NN is_VBZ still_RB controversial_JJ ,_, it_PP can_MD be_VB speculated_VBN that_IN sanitation_NN procedures_NNS ,_, vaccination_NN ,_, and_CC widespread_JJ antibiotic_JJ use_NN ,_, impeding_VBG host-to-host_NN spread_NN of_IN vir_NN plasmid-based_JJ pathogens_NNS ,_, may_MD reduce_VB the_DT overall_JJ pathogenic_JJ power_NN of_IN microorganisms_NNS ._SENT Due_JJ to_TO the_DT rapid_JJ acquisition_NN and_CC fixation_NN of_IN compensatory_JJ mutations_NNS by_IN bacteria_NNS ,_, experiments_NNS to_TO evaluate_VB the_DT biological_JJ cost_NN of_IN the_DT expression_NN of_IN novel_JJ antibiotic_JJ resistance_NN and_CC virulence_NN determinants_NNS are_VBP difficult_JJ to_TO perform_VB ._SENT Antibiotic_JJ resistance_NN and_CC virulence_NN can_MD be_VB acquired_VBN either_RB by_IN horizontal_JJ transfer_NN of_IN antibiotic_JJ resistance_NN genes_NNS or_CC by_IN mutation_NN ._SENT The_DT presence_NN of_IN new_JJ plasmids_NNS and_CC transposons_NNS in_IN the_DT bacterial_JJ genome_NN has_VBZ a_DT relevant_JJ cost_NN for_IN the_DT recipient_JJ bacteria_NNS ._SENT However_RB ,_, it_PP has_VBZ been_VBN demonstrated_VBN that_IN under_IN these_DT circumstances_NNS ,_, the_DT cost_NN is_VBZ compensated_VBN for_IN in_IN few_JJ generations_NNS as_IN the_DT consequence_NN of_IN genetic_JJ change_NN by_IN the_DT host_NN ,_, getting_VBG the_DT specific_JJ plasmid-bacterial_JJ strain_NN association_NN more_JJR fit_NN than_IN the_DT previous_JJ non-plasmid-containing_NN bacterium_NN ._SENT Also_RB ,_, in_IN the_DT case_NN of_IN mutations_NNS leading_VBG to_TO antibiotic_JJ resistance_NN ,_, some_DT examples_NNS demonstrate_VBP the_DT possibility_NN of_IN fitness_NN reduction_NN ,_, which_WDT may_MD also_RB reduce_VB bacterial_JJ virulence_NN (_( see_VB last_JJ example_NN in_IN previous_JJ section_NN )_) ._SENT For_IN instance_NN ,_, current_JJ evidence_NN supports_VBZ the_DT idea_NN that_IN highly_RB fluoroquinolone-resistant_JJ Salmonella_NP strains_NNS could_MD be_VB counterselected_VBN in_IN the_DT field_NN ._SENT A_DT substantial_JJ reduction_NN of_IN the_DT virulent_JJ characteristics_NNS has_VBZ been_VBN also_RB described_VBN for_IN antibiotic-resistant_JJ S._NP enterica_NN serotype_NN Typhimurium_NN isolates_NNS ._SENT Although_IN this_DT may_MD occur_VB for_IN some_DT bacteria_NNS ,_, it_PP does_VBZ not_RB mean_VB that_IN it_PP will_MD always_RB occur_VB ._SENT In_IN fact_NN ,_, an_DT outbreak_NN of_IN quinolone-resistant_JJ S._NP enterica_NN serotype_NN Typhimurium_NP DT104_NP has_VBZ recently_RB been_VBN described_VBN ,_, and_CC an_DT increase_NN in_IN quinolone-resistant_JJ Campylobacter_NP jejuni_NN infections_NNS has_VBZ been_VBN reported_VBN in_IN Minnesota_NP ._SENT The_DT emergence_NN of_IN compensatory_JJ mutations_NNS rapidly_RB alleviates_VBZ the_DT biological_JJ cost_NN of_IN antibiotic_JJ resistance_NN in_IN S._NP enterica_NP serotype_NN Typhimurium_NN isolates_NNS ,_, and_CC this_DT could_MD be_VB the_DT situation_NN for_IN the_DT aforementioned_JJ outbreaks_NNS of_IN quinolone-resistant_JJ bacteria_NNS ._SENT Noteworthy_JJ ,_, the_DT compensatory_JJ mutations_NNS that_WDT are_VBP selected_VBN in_IN vivo_JJ and_CC in_IN vitro_NN are_VBP different_JJ ,_, reflecting_VBG the_DT different_JJ growing_VBG conditions_NNS for_IN bacteria_NNS during_IN infection_NN compared_VBN with_IN microorganisms_NNS growing_VBG in_IN vitro_NN ._SENT This_DT indicates_VBZ that_IN the_DT metabolic_JJ requirements_NNS needed_VBN for_IN infection_NN are_VBP different_JJ from_IN those_DT for_IN surviving_VBG in_IN the_DT environment_NN ._SENT Therefore_RB ,_, acquisition_NN of_IN the_DT characteristics_NNS required_VBN for_IN infection_NN and_CC antibiotic_JJ resistance_NN might_MD make_VB them_PP less_RBR proficient_JJ for_IN surviving_VBG in_IN the_DT environment_NN and_CC to_TO be_VB transmitted_VBN among_IN different_JJ hosts_NNS ._SENT It_PP seems_VBZ then_RB that_DT acquisition_NN of_IN novel_NN virulence_NN and_CC antibiotic_JJ resistance_NN traits_NNS has_VBZ a_DT cost_NN in_IN bacterial_JJ fitness_NN ,_, but_CC the_DT cost_NN is_VBZ rapidly_RB compensated_VBN for_IN due_JJ to_TO the_DT high_JJ plasticity_NN of_IN bacterial_JJ genomes_NNS and_CC the_DT huge_JJ populations_NNS of_IN bacteria_NNS from_IN which_WDT compensatory_JJ mutants_NNS can_MD be_VB selected_VBN ._SENT However_RB ,_, this_DT situation_NN may_MD not_RB always_RB occur_VB ._SENT Possibly_RB ,_, only_RB those_DT mechanisms_NNS that_WDT can_MD be_VB compensated_VBN for_IN by_IN mutations_NNS in_IN other_JJ loci_NNS are_VBP selected_VBN because_IN these_DT are_VBP the_DT only_JJ ones_NNS that_WDT can_MD avoid_VB fitness_NN reduction_NN ._SENT As_IN stated_VBN by_IN other_JJ authors_NNS ,_, the_DT effect_NN of_IN antibiotic_JJ resistance_NN (_( and_CC in_IN a_DT higher_JJR grade_NN of_IN virulence_NN determinants_NNS )_) on_IN bacterial_JJ fitness_NN has_VBZ been_VBN properly_RB addressed_VBN in_IN only_RB a_DT few_JJ studies_NNS ._SENT This_DT topic_NN needs_VBZ to_TO be_VB investigated_VBN so_RB that_IN the_DT biological_JJ potential_NN of_IN novel_JJ virulent_JJ and_CC antibiotic-resistant_JJ bacteria_NNS may_MD be_VB predicted_VBN ._SENT As_IN previously_RB stated_VBN ,_, both_DT antibiotic_JJ resistance_NN genes_NNS and_CC virulence_NN determinants_NNS have_VBP been_VBN acquired_VBN by_IN horizontal_JJ gene_NN transfer_NN in_IN most_JJS cases_NNS ._SENT One_CD intriguing_JJ question_NN that_WDT has_VBZ not_RB been_VBN completely_RB resolved_VBN resides_VBZ in_IN the_DT origin_NN of_IN these_DT determinants_NNS ._SENT It_PP is_VBZ widely_RB accepted_VBN by_IN the_DT plasmids_NNS and_CC transposons_NNS that_WDT carry_VBP antibiotic_JJ resistance_NN genes_NNS may_MD have_VB originated_VBN in_IN antibiotic-producing_NN organisms_NNS in_IN order_NN to_TO avoid_VB the_DT deleterious_JJ effect_NN of_IN the_DT antibiotic_NN on_IN themselves_PP ._SENT Eventually_RB ,_, they_PP could_MD have_VB further_RBR evolved_VBN in_IN organisms_NNS in_IN an_DT ecological_JJ consortium_NN with_IN antibiotic_JJ producers_NNS ._SENT More_RBR recent_JJ works_NNS indicate_VBP that_IN this_DT hypothesis_NN about_IN the_DT origin_NN of_IN resistance_NN is_VBZ only_RB half_RB true_JJ ._SENT For_IN instance_NN ,_, it_PP is_VBZ difficult_JJ to_TO believe_VB that_IN chromosomal_JJ beta-lactamases_NNS as_RB well_RB as_IN some_DT aminoglycoside-inactivating_VBG enzymes_NNS and_CC a_DT plethora_NN of_IN MDR_NP determinants_NNS which_WDT are_VBP present_JJ in_IN all_DT isolates_NNS of_IN a_DT given_VBN bacterial_JJ species_NNS originated_VBN in_IN the_DT antibiotic_JJ producers_NNS ._SENT In_IN fact_NN ,_, all_PDT these_DT determinants_NNS must_MD have_VB a_DT functional_JJ role_NN other_JJ than_IN antibiotic_JJ resistance_NN ,_, and_CC this_DT phenotype_NN will_MD only_RB be_VB a_DT consequence_NN of_IN their_PP$ primary_JJ physiological_JJ function_NN (_( see_VB reference_NN for_IN a_DT review_NN of_IN this_DT concept_NN )_) ._SENT In_IN the_DT case_NN of_IN virulence_NN determinants_NNS ,_, the_DT current_JJ paradigm_NN indicates_VBZ that_IN pathogenicity_NN islands_NNS acquired_VBN through_IN horizontal_JJ gene_NN transfer_NN are_VBP frequently_RB responsible_JJ for_IN the_DT pathogenic_JJ properties_NNS of_IN virulent_JJ bacterial_JJ species_NNS ._SENT Different_JJ from_IN antibiotic_JJ resistance_NN genes_NNS ,_, the_DT pathogenicity_NN islands_NNS are_VBP more_RBR difficult_JJ to_TO explain_VB ,_, because_IN pathogenic_JJ bacterial_JJ ancestors_NNS carrying_VBG such_JJ gene_NN clusters_NNS have_VBP not_RB been_VBN detected_VBN ._SENT It_PP has_VBZ been_VBN proposed_VBN that_IN pathogenicity_NN islands_NNS might_MD be_VB relevant_JJ for_IN the_DT biodegradative_JJ properties_NNS of_IN microorganisms_NNS (_( including_VBG decomposition_NN of_IN dead_JJ bodies_NNS )_) ,_, to_TO kill_VB living_JJ cells_NNS (_( to_TO obtain_VB food_NN and_CC reduce_VB competition_NN )_) ,_, and_CC to_TO live_VB inside_IN eukaryotic_JJ cells_NNS (_( such_JJ as_IN amoeba_NN ,_, protozoa_NNS ,_, plants_NNS ,_, and_CC animals_NNS )_) in_IN natural_JJ environments_NNS ._SENT Antibiotic_JJ resistance_NN genes_NNS and_CC virulence_NN determinants_NNS might_MD then_RB play_VB a_DT different_JJ role_NN in_IN the_DT original_JJ organisms_NNS from_IN which_WDT they_PP were_VBD transferred_VBN to_TO pathogenic_JJ bacteria_NNS ._SENT However_RB ,_, once_RB those_DT determinants_NNS have_VBP been_VBN selected_VBN in_IN the_DT heterologous_JJ host_NN ,_, they_PP confer_VBP a_DT selective_JJ advantage_NN and_CC are_VBP fixed_VBN in_IN the_DT pathogenic_JJ bacterial_JJ populations_NNS ,_, where_WRB they_PP can_MD evolve_VB further_JJR and_CC eventually_RB be_VB transferred_VBN to_TO other_JJ bacterial_JJ species_NNS ._SENT Two_CD different_JJ processes_NNS account_VBP for_IN evolution_NN of_IN antibiotic_JJ resistance-virulence_NN phenotypes_NNS :_: gene_NN mutation_NN and_CC gene_NN recombination_NN (_( horizontal_JJ gene_NN transfer_NN included_VBD )_) ._SENT The_DT role_NN of_IN mutation_NN in_IN antibiotic_JJ resistance_NN is_VBZ well_RB known_VBN ._SENT In_IN the_DT case_NN of_IN virulence_NN ,_, fewer_JJR examples_NNS of_IN such_PDT a_DT role_NN have_VBP been_VBN described_VBN ._SENT However_RB ,_, mutational_JJ activation-inactivation_NN of_IN intrinsic_JJ genes_NNS might_MD also_RB contribute_VB to_TO a_DT virulent_JJ phenotype_NN in_IN the_DT case_NN of_IN opportunistic_JJ pathogens_NNS ._SENT As_IN an_DT example_NN of_IN cryptic_JJ virulence_NN determinants_NNS activatable_JJ by_IN mutations_NNS ,_, laboratory_NN isolates_NNS of_IN E._NP coli_NNS are_VBP hemolytic_JJ because_IN of_IN mutations_NNS in_IN the_DT hns_NNS and_CC fnr_NN genes_NNS ._SENT Whether_IN this_DT is_VBZ just_RB a_DT laboratory_NN curiosity_NN and_CC might_MD actually_RB have_VB a_DT role_NN in_IN the_DT course_NN of_IN nosocomial_JJ infections_NNS by_IN E._NP coli_NNS is_VBZ a_DT matter_NN of_IN speculation_NN ._SENT Some_DT virulence_NN determinants_NNS of_IN P._NP aeruginosa_NP ,_, such_JJ as_IN alginate_NN production_NN and_CC cytotoxicity_NN ,_, are_VBP downregulated_JJ ._SENT However_RB ,_, mutants_NNS in_IN which_WDT the_DT expression_NN of_IN such_JJ determinants_NNS is_VBZ derepressed_VBN are_VBP frequently_RB found_VBN during_IN infection_NN ._SENT This_DT indicates_VBZ that_DT mutation_NN probably_RB plays_VBZ a_DT major_JJ role_NN in_IN the_DT emergence_NN of_IN the_DT different_JJ virulent_JJ phenotypes_NNS shown_VBN by_IN P._NP aeruginosa_NP clinical_JJ isolates_NNS ._SENT Pathogenic_JJ P._NP aeruginosa_NP isolates_NNS can_MD be_VB broadly_RB classified_VBN into_IN two_CD groups_NNS ,_, those_DT with_IN a_DT cytoinvasive_JJ phenotype_NN and_CC those_DT with_IN a_DT cytotoxic_JJ phenotype_NN ._SENT However_RB ,_, both_DT kinds_NNS of_IN isolates_NNS contain_VBP the_DT genes_NNS required_VBN for_IN invading_VBG epithelial_JJ cells_NNS ._SENT Invasive_JJ and_CC cytotoxic_JJ strains_NNS differ_VBP in_IN the_DT expression_NN of_IN the_DT genes_NNS under_IN the_DT control_NN of_IN an_DT activator_NN called_VBN ExsA_NP ._SENT Mutations_NNS in_IN the_DT gene_NN exsA_NN ,_, which_WDT encodes_VBZ the_DT activator_NN ,_, lead_VB to_TO not_RB a_DT cytotoxic_JJ but_CC only_RB an_DT invasive_JJ phenotype_NN ._SENT Although_IN both_DT types_NNS of_IN bacteria_NNS are_VBP virulent_JJ ,_, they_PP occupy_VBP different_JJ environments_NNS (_( inside_IN and_CC outside_IN epithelial_JJ cells_NNS )_) ,_, so_RB that_IN one_PP or_CC the_DT other_JJ phenotype_NN might_MD be_VB selected_VBN in_IN vivo_JJ by_IN ,_, for_IN the_DT moment_NN ,_, unknown_JJ processes_NNS ._SENT Recombination_NN also_RB has_VBZ an_DT important_JJ role_NN in_IN the_DT evolution_NN of_IN antibiotic_JJ resistance_NN determinants_NNS ._SENT Progressive_JJ clustering_VBG of_IN genes_NNS ,_, leading_VBG to_TO an_DT operon_NN structure_NN ,_, may_MD have_VB occurred_VBN to_TO optimize_VB and_CC regulate_VB the_DT expression_NN of_IN ancient_JJ genes_NNS producing_VBG a_DT resistance_NN (_( frequently_RB low-level_JJ resistance_NN )_) phenotype_NN ._SENT In_IN a_DT similar_JJ way_NN ,_, the_DT construction_NN of_IN a_DT pathogenicity_NN island_NN requires_VBZ the_DT recruitment_NN of_IN different_JJ genes_NNS that_WDT recombine_VBP to_TO produce_VB a_DT single_JJ genetic_JJ element_NN containing_VBG several_JJ genes_NNS with_IN a_DT common_JJ role_NN ,_, virulence_NN ._SENT In_IN other_JJ cases_NNS ,_, intragenic_JJ recombination_NN is_VBZ essential_JJ to_TO produce_VB a_DT resistant_JJ phenotype_NN ._SENT The_DT most_RBS conspicuous_JJ example_NN of_IN recombination_NN in_IN chromosomal_JJ DNA_NN leading_VBG to_TO antibiotic_JJ resistance_NN is_VBZ beta-lactam_NN resistance_NN produced_VBN by_IN recombination_NN of_IN penicillin-binding-protein_NN genes_NNS in_IN Neisseria_NP gonorrhoeae_NNS and_CC Streptococcus_NN pneumoniae_NNS ._SENT Similar_JJ recombinatorial_JJ processes_NNS may_MD have_VB influenced_VBN the_DT evolution_NN of_IN virulence_NN ._SENT However_RB ,_, unlike_IN for_IN antibiotic_JJ resistance_NN ,_, few_JJ examples_NNS of_IN recent_JJ evolution_NN of_IN bacteria_NNS to_TO a_DT virulent_JJ phenotype_NN have_VBP been_VBN described_VBN ._SENT One_PP might_MD be_VB recombination_NN between_IN different_JJ sets_NNS of_IN genes_NNS ,_, which_WDT causes_VBZ the_DT rearrangements_NNS that_WDT can_MD be_VB observed_VBN in_IN the_DT capsular_NN antigens_NNS of_IN S._NP pneumoniae_NNS (_( -_: ,_, )_) and_CC can_MD be_VB considered_VBN a_DT mechanism_NN of_IN defense_NN against_IN host_NN immunity_NN ._SENT Another_DT could_MD be_VB the_DT emergence_NN and_CC further_JJR dissemination_NN of_IN enterohemorrhagic_JJ E._NP coli_NNS O157:H7_JJ strains_NNS ._SENT This_DT E._NP coli_NNS serogroup_NN has_VBZ emerged_VBN as_IN a_DT relevant_JJ pathogen_NN in_IN the_DT last_JJ 20_CD years_NNS ._SENT Enterohemorrhagic_NP E._NP coli_NNS isolates_NNS contain_VBP virulence_NN plasmids_NNS and_CC pathogenicity_NN islands_NNS similar_JJ to_TO those_DT found_VBN in_IN Shigella_NP spp._NP ._SENT Although_IN it_PP was_VBD a_DT matter_NN of_IN speculation_NN whether_IN these_DT genetic_JJ determinants_NNS were_VBD acquired_VBN recently_RB by_IN E._NP coli_NNS ,_, the_DT recent_JJ sequencing_VBG of_IN the_DT genome_NN of_IN an_DT E._NP coli_NNS O157:H7_JJ strain_NN demonstrated_VBD that_IN it_PP contains_VBZ as_RB many_JJ as_IN 1,387_CD new_JJ genes_NNS in_IN comparison_NN with_IN the_DT previously_RB sequenced_JJ nonpathogenic_JJ laboratory_NN strain_NN E._NP coli_NNS K-12_NP ._SENT We_PP must_MD be_VB aware_JJ that_IN acquisition_NN of_IN pathogenicity_NN determinants_NNS by_IN previously_RB nonpathogenic_JJ organisms_NNS might_MD occur_VB in_IN a_DT similar_JJ way_NN as_IN it_PP happens_VBZ with_IN antibiotic_JJ resistance_NN determinants_NNS ._SENT For_IN instance_NN ,_, the_DT acquisition_NN of_IN virulence_NN plasmids_NNS by_IN bacteria_NNS forming_VBG part_NN of_IN the_DT human_JJ indigenous_JJ flora_NN and_CC thus_RB already_RB well_RB adapted_VBN for_IN surviving_VBG inside_IN their_PP$ host_NN (_( such_JJ as_IN E._NP coli_NNS )_) might_MD lead_VB to_TO the_DT emergence_NN of_IN novel_NN pathogens_NNS ._SENT In_IN a_DT similar_JJ way_NN ,_, the_DT acquisition_NN of_IN virulence_NN determinant_NN 